Efficient allocation of novel agents in multiple myeloma: a work in progress
- PMID: 23299778
- PMCID: PMC3556256
- DOI: 10.1634/theoncologist.2012-0484
Efficient allocation of novel agents in multiple myeloma: a work in progress
Abstract
This commentary examines key questions regarding the use of novel agents in multiple myeloma, addressed by two articles in this month's issue.
Conflict of interest statement
Disclosures of potential conflicts of interest may be found at the end of this article.
Comment on
- 
  
  Health care costs and resource utilization, including patient burden, associated with novel-agent-based treatment versus other therapies for multiple myeloma: findings using real-world claims data.Oncologist. 2013;18(1):37-45. doi: 10.1634/theoncologist.2012-0113. Epub 2013 Jan 8. Oncologist. 2013. PMID: 23299776 Free PMC article.
- 
  
  The cost-effectiveness of initial treatment of multiple myeloma in the U.S. with bortezomib plus melphalan and prednisone versus thalidomide plus melphalan and prednisone or lenalidomide plus melphalan and prednisone with continuous lenalidomide maintenance treatment.Oncologist. 2013;18(1):27-36. doi: 10.1634/theoncologist.2011-0380. Epub 2013 Jan 8. Oncologist. 2013. PMID: 23299777 Free PMC article.
References
- 
    - Macready N. The climbing costs of cancer care. J Natl Cancer Inst. 2011;103(19):1433–1435. - PubMed
 
- 
    - McCabe C, Bergmann L, Bosanquet N, et al. Market and patient access to new oncology products in Europe: a current, multidisciplinary perspective. Ann Oncol. 2009;20(3):403–412. - PubMed
 
- 
    - Bach PB. Limits on Medicare's ability to control rising spending on cancer drugs. N Engl J Med. 2009;360(6):626–633. - PubMed
 
- 
    - Jonsson B, Wilking N. A global comparison regarding patient access to cancer drugs. Ann Oncol. 2007;18(Suppl 3):iii1–iii77. - PubMed
 
- 
    - Mahindra A, Cirstea D, Raje N. Novel therapeutic targets for multiple myeloma. Future Oncol. 2010;6(3):407–418. - PubMed
 
Publication types
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Medical
 
        